Dr. Scott Gottlieb Visits Eagle’s New Facility
Former FDA Commissioner Dr. Scott Gottlieb visited the Eagle Facility on Thursday, October 10th, 2019.Thank you for reading this post, don't forget to subscribe!
Eagle President and CEO Dr. Ross Caputo took the opportunity to share our mission of ensuring the safety and quality of compounded preparations through science-based solutions. Dr. Gottlieb was also given an overview of Eagle’s aim to impact the compounding industry by promoting practices that both meet and exceed regulatory expectations.
Gottlieb served as the 23rd Commissioner of the FDA from May 2017 to April 2019. He is a physician, medical policy expert, and public health advocate who previously served as the FDA’s Deputy Commissioner for Medical and Scientific Affairs, and before that, as a senior advisor to the FDA Commissioner (1).
References:
(1) https://www.fda.gov/node/373545 – US Food and Drug Administration. Retrieved October 11, 2019
(1) https://www.fda.gov/node/373545 – US Food and Drug Administration. Retrieved October 11, 2019
Eagle is a U.S. Food and Drug Administration (FDA) and Drug Enforcement Agency (DEA) registered A2LA ISO 17025 accredited laboratory founded in 2003 that provides analytical chemistry and microbiological testing, consultation services, and other technical services for pharmacies, highly regulated industries, and research organizations to support their compliance needs.
Latest posts by Eagle Analytical (see all)
- Eagle New Year Party & Eagle Employee Of The Year Award Ceremony, 01/13 - March 11, 2024
- HRT Functional Medicine Symposium, 02/15 – 02/17 - March 11, 2024
- APhA, 03/22 – 03/25 - March 11, 2024
